Listen to Rob, CEO, and previous CEO multiple times plus corporate board member for several companies in the industry, discuss this niche in the pharma world. A publicly traded company, focusing on the delivery system of medications, w/systems offering less toxicology and fewer side effects. W/a proprietary system they offer a delivery system that is unique and is not processed thru the stomach. Many investors should find this interview and company to be very interesting.
Create your
podcast in
minutes
It is Free